netFormulary Leicestershire Health Community NHS
Medicines Formulary  
 Search
 Results

Looking for Adalimumab found 25 matches

Formulary items 5 matches
Non-formulary items 1 match
   
Formulary BNF Category
  Restricted Drug  Adalimumab  (Rheumatology) Cytokine modulators - 10.01.03
  Restricted Drug  Adalimumab  (Dermatology) Drugs affecting the immune response - 13.05.03
  Restricted Drug  Adalimumab  (Opthalmology) Other anti-inflammatory preparations - 11.04.02
  Restricted Drug  Adalimumab  (Gastroenterology) Cytokine inhibitors - 01.05
  Restricted Drug  Adalimumab (Immunology) Unlicensed Medicines - 20
 
Non Formulary BNF Category
  Adalimumab Unlicensed Medicines - 20


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section Leicestershire Evaluation: Adalimumab in Behcet’s (20)
link in drug section Leicestershire Evaluation: Adalimumab in Panuveitis (20)
link in drug section NICE TA 146: Psoriasis - Adalimumab (13.05.03)
link in drug section NICE TA 187: Crohns disease- Infliximab and Adalimumab (01.05)
link in drug section NICE TA 187: Crohns disease- Infliximab and Adalimumab (01.05)
link in subsection NICE TA 195: RA - Adalimumab, etanercept, infliximab, rituximab, abatacept after failure of a TNF  (10.01.03)
link in subsection NICE TA 199: Psoriatic arthritis: Etanercept, infliximab and adalimumab (10.01.03)
link in drug section NICE TA 329: Adalimumab for moderately to severely active ulcerative colitis  (01.05)
link in drug section NICE TA 373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis  (10.01.03)
link in drug section NICE TA 373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis  (10.01.03)
link in drug section NICE TA 373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis  (10.01.03)
link in drug section NICE TA 373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis  (10.01.03)
link in subsection NICE TA 373: Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis  (10.01.03)
link in subsection NICE TA 375: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed (Replaced TA130 Jan 2016) (10.01.03)
link in drug section NICE TA 375: Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed (Replaced TA186 Jan 2016) (10.01.03)
link in drug section NICE TA 392: Adalimumab for treating moderate to severe hidradenitis suppurativa (13.05.03)
link in drug section NICE TA 455: Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people (13.05.03)
link in drug section NICE TA 460: Adalimumab and dexamethasone for treating non-infectious uveitis (11.04.01)
link in drug section NICE TA 460: Adalimumab and dexamethasone for treating non-infectious uveitis (11.04.02)


 

netFormulary